Cigna Group — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Cigna Group filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | $69.75B | Oct 30, 2025 |
| Q2 | 2025 | Jun 30, 2025 | $67.18B | Jul 31, 2025 |
| Q1 | 2025 | Mar 31, 2025 | $65.50B | May 2, 2025 |
| Q3 | 2025 | Sep 30, 2024 | $63.69B | Oct 30, 2025 |
| Q2 | 2025 | Jun 30, 2024 | $60.52B | Jul 31, 2025 |
| Q1 | 2025 | Mar 31, 2024 | $57.26B | May 2, 2025 |
| Q3 | 2024 | Sep 30, 2023 | $49.05B | Oct 31, 2024 |
| Q2 | 2024 | Jun 30, 2023 | $48.59B | Aug 1, 2024 |
| Q1 | 2024 | Mar 31, 2023 | $46.52B | May 2, 2024 |
| Q3 | 2023 | Sep 30, 2022 | $45.28B | Nov 2, 2023 |
| Q2 | 2023 | Jun 30, 2022 | $45.48B | Aug 3, 2023 |
| Q1 | 2023 | Mar 31, 2022 | $44.01B | May 5, 2023 |
| Q3 | 2022 | Sep 30, 2021 | $44.29B | Nov 3, 2022 |
| Q2 | 2022 | Jun 30, 2021 | $43.13B | Aug 4, 2022 |
| Q1 | 2022 | Mar 31, 2021 | $40.97B | May 6, 2022 |
| Q3 | 2021 | Sep 30, 2020 | $40.96B | Nov 4, 2021 |
| Q2 | 2021 | Jun 30, 2020 | $39.27B | Aug 5, 2021 |
| Q1 | 2021 | Mar 31, 2020 | $38.47B | May 7, 2021 |
| Q3 | 2020 | Sep 30, 2019 | $38.56B | Nov 5, 2020 |
| Q2 | 2020 | Jun 30, 2019 | $38.82B | Aug 6, 2020 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | $2.58B | Oct 30, 2025 |
| Q2 | 2025 | Jun 30, 2025 | $2.31B | Jul 31, 2025 |
| Q1 | 2025 | Mar 31, 2025 | $1.97B | May 2, 2025 |
| Q3 | 2025 | Sep 30, 2024 | $2.58B | Oct 30, 2025 |
| Q2 | 2025 | Jun 30, 2024 | $2.41B | Jul 31, 2025 |
| Q1 | 2025 | Mar 31, 2024 | $2.26B | May 2, 2025 |
| Q3 | 2024 | Sep 30, 2023 | $2.24B | Oct 31, 2024 |
| Q2 | 2024 | Jun 30, 2023 | $2.22B | Aug 1, 2024 |
| Q1 | 2024 | Mar 31, 2023 | $2.02B | May 2, 2024 |
| Q3 | 2023 | Sep 30, 2022 | $2.14B | Nov 2, 2023 |
| Q2 | 2023 | Jun 30, 2022 | $2.37B | Aug 3, 2023 |
| Q1 | 2023 | Mar 31, 2022 | $2.19B | May 5, 2023 |
| Q3 | 2022 | Sep 30, 2021 | $2.29B | Nov 3, 2022 |
| Q2 | 2022 | Jun 30, 2021 | $2.15B | Aug 4, 2022 |
| Q1 | 2022 | Mar 31, 2021 | $1.96B | May 6, 2022 |
| Q3 | 2021 | Sep 30, 2020 | $2.11B | Nov 4, 2021 |
| Q2 | 2021 | Jun 30, 2020 | $2.64B | Aug 5, 2021 |
| Q1 | 2021 | Mar 31, 2020 | $2.06B | May 7, 2021 |
| Q3 | 2020 | Sep 30, 2019 | $2.12B | Nov 5, 2020 |
| Q2 | 2020 | Jun 30, 2019 | $2.16B | Aug 6, 2020 |